Your browser doesn't support javascript.
Considerations for the Safe Operation of Schools During the Coronavirus Pandemic.
Lordan, Ronan; Prior, Samantha; Hennessy, Elizabeth; Naik, Amruta; Ghosh, Soumita; Paschos, Georgios K; Skarke, Carsten; Barekat, Kayla; Hollingsworth, Taylor; Juska, Sydney; Mazaleuskaya, Liudmila L; Teegarden, Sarah; Glascock, Abigail L; Anderson, Sean; Meng, Hu; Tang, Soon-Yew; Weljie, Aalim; Bottalico, Lisa; Ricciotti, Emanuela; Cherfane, Perla; Mrcela, Antonijo; Grant, Gregory; Poole, Kristen; Mayer, Natalie; Waring, Michael; Adang, Laura; Becker, Julie; Fries, Susanne; FitzGerald, Garret A; Grosser, Tilo.
  • Lordan R; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Prior S; Faculty of Science & Engineering, University of Limerick, Limerick, Ireland.
  • Hennessy E; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Naik A; Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Ghosh S; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Paschos GK; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Skarke C; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Barekat K; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Hollingsworth T; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Juska S; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Mazaleuskaya LL; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Teegarden S; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Glascock AL; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Anderson S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Meng H; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Tang SY; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Weljie A; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Bottalico L; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Ricciotti E; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Cherfane P; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Mrcela A; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Grant G; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Poole K; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Mayer N; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Waring M; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Adang L; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Becker J; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Fries S; Department of English, University of Delaware, Newark, DE, United States.
  • FitzGerald GA; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Grosser T; Department of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, United States.
Front Public Health ; 9: 751451, 2021.
Article in English | MEDLINE | ID: covidwho-1606247
ABSTRACT
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, providing safe in-person schooling has been a dynamic process balancing evolving community disease burden, scientific information, and local regulatory requirements with the mandate for education. Considerations include the health risks of SARS-CoV-2 infection and its post-acute sequelae, the impact of remote learning or periods of quarantine on education and well-being of children, and the contribution of schools to viral circulation in the community. The risk for infections that may occur within schools is related to the incidence of SARS-CoV-2 infections within the local community. Thus, persistent suppression of viral circulation in the community through effective public health measures including vaccination is critical to in-person schooling. Evidence suggests that the likelihood of transmission of SARS-CoV-2 within schools can be minimized if mitigation strategies are rationally combined. This article reviews evidence-based approaches and practices for the continual operation of in-person schooling.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Child / Humans Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.751451

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Child / Humans Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.751451